Varicella Zoster Virus (VZV), a member of the herpesvirus family, is the etiological agent of varicella (chickenpox) and herpes zoster (shingles). Accurate serological detection of VZV-specific antibodies is critical for diagnosis, immunity assessment, and epidemiological studies.
The Varicella Zoster Virus ELISA Kit is a robust immunoassay designed for the qualitative and quantitative detection of human IgG antibodies against VZV in serum, plasma, or other biological fluids. This kit provides rapid and sensitive measurement of VZV immune status to support clinical and research applications.
Performance Features
- Sensitivity: High sensitivity allows detection at very low antibody levels.
- Specificity: The kit shows no cross-reactivity with other herpesviruses or related antigens, ensuring accurate VZV-specific antibody detection.
- Reproducibility: The intra- and inter-assay variability is low, indicating high precision.
- Interference: No significant interference from common serum components or related molecules has been observed.
Applications
- Determination of immune status post-vaccination or natural infection.
- Diagnosis of VZV infection in clinical samples.
- Epidemiological surveillance and vaccine efficacy studies.
- Research applications in virology and immunology related to VZV.
The Varicella Zoster Virus ELISA Kit offers a sensitive, specific, and user-friendly platform for detecting human anti-VZV IgG antibodies. It is an essential tool for clinicians and researchers monitoring VZV immunity and infection, aiding in control and prevention strategies against varicella and herpes zoster diseases.
